Clinical Trial - Trial jRCT2061220034
Access comprehensive clinical trial information for jRCT2061220034 through Pure Global AI's free database. This phase not specified trial is sponsored by Boehringer Ingelheim and is currently Recruiting. The study focuses on schizophrenia.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Japan Registry Clinical Trial data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Free Database
Powered by Pure Global AI
840K+ Trials
jRCT2061220034
Recruiting
Trial Details
Japan Registry Clinical Trial • jRCT2061220034
Untitled Trial
An open label, single arm, extension trial to examine long term safety of BI 425809 once daily in patients with schizophrenia who have completed previous BI 425809 Phase III trials.(CONNEX X)
Study Focus
Interventional
Sponsor & Location
Boehringer Ingelheim
Korea;Germany;United States of America;China;Taiwan;Mexico;Italy
Timeline & Enrollment
N/A
N/A
N/A
ICD-10 Classifications
Schizophrenia
Simple schizophrenia
Schizophrenia, unspecified
Other schizophrenia
Paranoid schizophrenia
Data Source
Japan Registry Clinical Trial
jRCT2061220034
Non-Device Trial